Skip to content
Brand AI

Micot Pharma

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2026

    Micot Pharma debuts MT200605 Huntington's disease research in poster presentation at MDS 2026

    Micot Pharma (2335.HK) presented for the first time, in an electronic poster at the MDS 2026 congress in Seoul, nonclinical findings in Huntington's disease and Phase I clinical results in healthy volunteers for its independently developed drug candidate MT200605, a small-molecule TrkB agonist. Together with previously announced positive Phase II data in acute ischemic stroke, the findings establish a development path for the candidate from acute brain injury into neurodegenerative diseases.

    Source